VRTX is trading 4.5% up at $501.91 as the stock extends a multi-day rebound and breaks above recent resistance near $483.

  • The move continues a strong short-term uptrend supported by bullish analyst views and prior institutional interest.
  • There are no fresh company-specific headlines, earnings, or FDA decisions on June 26, 2026, clearly tied to the price action.
  • The stock is showing significant strength despite a slightly weaker backdrop in the broader market.